Biomarker directed treatment in metastatic colorectal cancer
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AMGT-ERCC1
- 23 Nov 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018.
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2015 Planned number of patients changed from 30 to 50, according to European Clinical Trials Database record.